Ixazomib in combination with carboplatin in pretreated women with advanced triple negative breast cancer, an ongoing phase I/II trial (AGMT MBC-10 trial)

Gabriel Rinnerthaler; Simon Peter Gampenrieder; A Petzer; R Pusch; D Voskova; D Rossmann; M Balic; D Egle; H Rumpold; CF Singer; Thomas Melchardt; H Ulmer; B Mlineritsch; Richard Greil

doi:10.1158/1538-7445.AM2018-CT160

Ixazomib in combination with carboplatin in pretreated women with advanced triple negative breast cancer, an ongoing phase I/II trial (AGMT MBC-10 trial)

Gabriel Rinnerthaler, Simon Peter Gampenrieder, A Petzer, R Pusch, D Voskova, D Rossmann, M Balic, D Egle, H Rumpold, CF Singer, Thomas Melchardt, H Ulmer, B Mlineritsch, Richard Greil

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Abstract (Journal) › peer-review

Original language	English
Journal	CANCER RESEARCH
Volume	78
Issue number	13
DOIs	https://doi.org/10.1158/1538-7445.AM2018-CT160
Publication status	Published - 2018
Event	Annual Meeting of the American-Association-for-Cancer-Research (AACR) - Chicago, IL Duration: 14 Apr 2018 → 18 Apr 2018

Access to Document

10.1158/1538-7445.AM2018-CT160

Cite this

Rinnerthaler, G., Gampenrieder, S. P., Petzer, A., Pusch, R., Voskova, D., Rossmann, D., Balic, M., Egle, D., Rumpold, H., Singer, CF., Melchardt, T., Ulmer, H., Mlineritsch, B., & Greil, R. (2018). Ixazomib in combination with carboplatin in pretreated women with advanced triple negative breast cancer, an ongoing phase I/II trial (AGMT MBC-10 trial). CANCER RESEARCH , 78(13). https://doi.org/10.1158/1538-7445.AM2018-CT160

Rinnerthaler, Gabriel ; Gampenrieder, Simon Peter ; Petzer, A et al. / Ixazomib in combination with carboplatin in pretreated women with advanced triple negative breast cancer, an ongoing phase I/II trial (AGMT MBC-10 trial). In: CANCER RESEARCH 2018 ; Vol. 78, No. 13.

@article{f9d67300cca2483f8ffff2533478fb41,

title = "Ixazomib in combination with carboplatin in pretreated women with advanced triple negative breast cancer, an ongoing phase I/II trial (AGMT MBC-10 trial)",

author = "Gabriel Rinnerthaler and Gampenrieder, {Simon Peter} and A Petzer and R Pusch and D Voskova and D Rossmann and M Balic and D Egle and H Rumpold and CF Singer and Thomas Melchardt and H Ulmer and B Mlineritsch and Richard Greil",

year = "2018",

doi = "10.1158/1538-7445.AM2018-CT160",

language = "English",

volume = "78",

journal = "CANCER RESEARCH ",

issn = "0008-5472",

publisher = "Amer Assoc Cancer Research",

number = "13",

note = "Annual Meeting of the American-Association-for-Cancer-Research (AACR) ; Conference date: 14-04-2018 Through 18-04-2018",

}

Rinnerthaler, G , Gampenrieder, SP, Petzer, A, Pusch, R, Voskova, D, Rossmann, D, Balic, M, Egle, D, Rumpold, H, Singer, CF, Melchardt, T, Ulmer, H, Mlineritsch, B & Greil, R 2018, 'Ixazomib in combination with carboplatin in pretreated women with advanced triple negative breast cancer, an ongoing phase I/II trial (AGMT MBC-10 trial)', CANCER RESEARCH , vol. 78, no. 13. https://doi.org/10.1158/1538-7445.AM2018-CT160

Ixazomib in combination with carboplatin in pretreated women with advanced triple negative breast cancer, an ongoing phase I/II trial (AGMT MBC-10 trial). / Rinnerthaler, Gabriel ; Gampenrieder, Simon Peter; Petzer, A et al.
In: CANCER RESEARCH , Vol. 78, No. 13, 2018.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - Ixazomib in combination with carboplatin in pretreated women with advanced triple negative breast cancer, an ongoing phase I/II trial (AGMT MBC-10 trial)

AU - Rinnerthaler, Gabriel

AU - Gampenrieder, Simon Peter

AU - Petzer, A

AU - Pusch, R

AU - Voskova, D

AU - Rossmann, D

AU - Balic, M

AU - Egle, D

AU - Rumpold, H

AU - Singer, CF

AU - Melchardt, Thomas

AU - Ulmer, H

AU - Mlineritsch, B

AU - Greil, Richard

PY - 2018

Y1 - 2018

U2 - 10.1158/1538-7445.AM2018-CT160

DO - 10.1158/1538-7445.AM2018-CT160

M3 - Abstract (Journal)

SN - 0008-5472

VL - 78

JO - CANCER RESEARCH

JF - CANCER RESEARCH

IS - 13

T2 - Annual Meeting of the American-Association-for-Cancer-Research (AACR)

Y2 - 14 April 2018 through 18 April 2018

ER -

Rinnerthaler G , Gampenrieder SP, Petzer A, Pusch R, Voskova D, Rossmann D et al. Ixazomib in combination with carboplatin in pretreated women with advanced triple negative breast cancer, an ongoing phase I/II trial (AGMT MBC-10 trial). CANCER RESEARCH . 2018;78(13). doi: 10.1158/1538-7445.AM2018-CT160